Vaccination and Screening for the Prevention of Cervical Cancer: Health Effects and Cost-effectiveness
Cancer of the cervix uteri is the third most common cancer among women worldwide. The incidence and mortality in the Netherlands, however, are very low, partly because of an effective screening programme. Next to the well-known conventional Pap smear, other medical interventions are available and have been developed more recently to prevent death from cervical cancer. This is, amongst others, liquid-based cytology, HPV DNA screening, and HPV vaccination. This thesis presents health effects and cost-effectiveness of cervical cancer screening and HPV vaccination, in the Netherlands as well as internationally.
|Publisher||Erasmus MC: University Medical Center Rotterdam|
|Promotor||Habbema, J.D.F. (Dik)|
|Sponsor||Erasmus MC Rotterdam|
|Keywords||cervical cancer, cost-effectiveness, developing countries, prevention, screening, vaccination|
de Kok de, I.M.C.M.. (2011, February 16). Vaccination and Screening for the Prevention of Cervical Cancer: Health Effects and Cost-effectiveness. Erasmus MC: University Medical Center Rotterdam. Retrieved from http://hdl.handle.net/1765/22651